Embla Medical hf EMBLA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- DKK 26.35
- Day Range
- DKK 26.45–27.40
- 52-Week Range
- DKK 25.00–37.90
- Bid/Ask
- DKK 26.60 / DKK 26.90
- Shares Outstanding
- 425.28M
- Market Cap
- DKK 11.31B
- Volume/Avg
- 41,718 / 79,813
Key Statistics
- Price/Earnings (Normalized)
- 18.71
- Price/Sales
- 1.79
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.77%
Company Profile
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 4,500
- Website
- https://www.emblamedical.com
Valuation
|
Metric
|
EMBLA
|
|---|---|
Price/Earnings (Normalized) | 18.71 |
Price/Book Value | 1.86 |
Price/Sales | 1.79 |
Price/Cash Flow | 12.16 |
Price/Earnings
EMBLA
Financial Strength
|
Metric
|
EMBLA
|
|---|---|
Quick Ratio | 0.67 |
Current Ratio | 1.25 |
Interest Coverage | 6.66 |
Quick Ratio
EMBLA
Profitability
|
Metric
|
EMBLA
|
|---|---|
Return on Assets (Normalized) | 5.51% |
Return on Equity (Normalized) | 10.70% |
Return on Invested Capital (Normalized) | 7.59% |
Return on Assets
EMBLA
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|#!VNCz | LOCK|@&^Q | $169B | |||
| Medtronic PLC
MDT
| LOCK|%Kq>WM | LOCK|GGmH | $110B | |||
| Stryker Corp
SYK
| LOCK|kmjZpj>z | LOCK|y@$ | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|!QYp!W | LOCK|&DJ$< | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|f>JvtVW& | LOCK|^@w# | $49B | |||
| DexCom Inc
DXCM
| LOCK|Qf&sZ$D | LOCK|&G?H | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|gTP#&$ | LOCK|K#! | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|%# | LOCK|yK | $23B | |||
| Steris PLC
STE
| LOCK|^fqRCZ | LOCK|@h#Z | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|^scx^!W | LOCK|tP | $17B |
United States